Literature DB >> 12708904

Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma.

Maamoun Al-Aynati1, Vicky Chen, Samih Salama, Hafez Shuhaibar, Darin Treleaven, Lydia Vincic.   

Abstract

CONTEXT: Histologic grading of renal cell carcinoma has been shown to be second to staging in prognostic significance. A 4-tier grading scheme proposed by Fuhrman et al and based on nuclear features is the system used most frequently in North America. There are, however, very few studies in the literature assessing the interobserver variability for this system, and to our knowledge, none addressing intraobserver variability.
OBJECTIVE: To assess the interobserver and intraobserver agreement among 4 pathologists using the Fuhrman nuclear grading scheme for renal cell carcinoma.
DESIGN: Representative hematoxylin-eosin-stained slides of 99 consecutive primary renal cell carcinoma cases diagnosed between 1994 and 1999 at St Joseph's Hospital, Hamilton, Ontario, were independently graded by 4 pathologists on 2 occasions with a minimum period of 3 months separating the 2 readings.
RESULTS: Intraobserver kappa values ranged from 0.29 to 0.62 (mean = 0.45), and interobserver kappa values ranged from 0.19 to 0.38 and from 0.09 to 0.44 for the first and second rounds, respectively (combined mean kappa value = 0.29). When combining Fuhrman grades 1 and 2 as low-grade tumors and grades 3 and 4 as high-grade tumors, the intraobserver kappa values ranged from 0.4 to 0.64 (mean = 0.53) and interobserver kappa values ranged from 0.28 to 0.59 and from 0.26 to 0.58 for the first and second rounds, respectively (combined mean kappa value = 0.45). The admixture of 2 grades in the same tumor was observed in 53% of cases.
CONCLUSIONS: We found only moderate intraobserver and interobserver agreement using the 4-grade Fuhrman scheme. After collapsing the diagnostic grades to 2, the intraobserver agreement changed from moderate to substantial. The collapsing of the 4-category Fuhrman grades into 2 categories is useful in improving intraobserver agreement.

Entities:  

Mesh:

Year:  2003        PMID: 12708904     DOI: 10.5858/2003-127-0593-IAIVUT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  24 in total

Review 1.  Should Small Renal Masses Be Biopsied?

Authors:  Ricardo R N Leão; Ardalan E Ahmad; Patrick O Richard
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

2.  Solidifying prognosis after surgery for renal cell carcinoma.

Authors:  Michael J Leveridge
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

3.  Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.

Authors:  Ning Liu; Weidong Gan; Feng Qu; Zhen Wang; Wenyuan Zhuang; Sezim Agizamhan; Linfeng Xu; Juanjuan Yin; Hongqian Guo; Dongmei Li
Journal:  Am J Pathol       Date:  2018-04       Impact factor: 4.307

Review 4.  Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management.

Authors:  Andrew W Silagy; Alejandro Sanchez; Brandon J Manley; Karim Bensalah; Axel Bex; Jose A Karam; Börje Ljungberg; Brian Shuch; A Ari Hakimi
Journal:  Eur Urol Focus       Date:  2019-04-28

Review 5.  Best Practice No 180. Nephrectomy for renal tumour; dissection guide and dataset.

Authors:  S Fleming; D F R Griffiths
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

6.  Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes.

Authors:  Chisato Ohe; Takashi Yoshida; Mahul B Amin; Naho Atsumi; Junichi Ikeda; Kazuho Saiga; Yuri Noda; Yoshiki Yasukochi; Riuko Ohashi; Haruyuki Ohsugi; Koichiro Higasa; Hidefumi Kinoshita; Koji Tsuta
Journal:  Mod Pathol       Date:  2021-11-30       Impact factor: 7.842

Review 7.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

8.  Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade.

Authors:  Hebert Alberto Vargas; Holly G Delaney; Eithne M Delappe; Ya Wang; Junting Zheng; Chaya S Moskowitz; Yongqiang Tan; Binsheng Zhao; Lawrence H Schwartz; Hedvig Hricak; Paul Russo; Oguz Akin
Journal:  J Magn Reson Imaging       Date:  2012-11-13       Impact factor: 4.813

Review 9.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

10.  Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma.

Authors:  N S Vasudev; S Sim; D A Cairns; R E Ferguson; R A Craven; A Stanley; J Cartledge; D Thompson; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.